Jane Street Group, LLC Galapagos Nv Call Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	SELL	$51.32 - $68.5 $15,396 - $20,550	-300 Reduced 4.29%	6,700 $416,000
Q2 2021 Aug 16, 2021	SELL	$68.86 - $83.34 $371,844 - $450,036	-5,400 Reduced 43.55%	7,000 $482,000
Q1 2021 May 18, 2021	SELL	$76.15 - $111.94 $1.16 Million - $1.7 Million	-15,200 Reduced 55.07%	12,400 $956,000
Q4 2020 Feb 17, 2021	SELL	$96.85 - $148.25 $1.3 Million - $1.99 Million	-13,400 Reduced 32.68%	27,600 $2.73 Million
Q3 2020 Nov 17, 2020	SELL	$122.47 - $213.56 $23 Million - $40 Million	-187,400 Reduced 82.05%	41,000 $5.82 Million
Q2 2020 Aug 17, 2020	BUY	$185.52 - $231.25 $42.4 Million - $52.8 Million	228,400 New	228,400 $45.1 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.85B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.